45 related articles for article (PubMed ID: 19895791)
1. Sulfatide Deficiency, an Early Alzheimer's Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks.
Palavicini JP; Ding L; Pan M; Qiu S; Wang H; Shen Q; Dupree JL; Han X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613677
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy.
Singh N; Singh AK
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128780. PubMed ID: 38104688
[TBL] [Abstract][Full Text] [Related]
3. A comparative scRNAseq data analysis to match mouse models with human kidney disease at the molecular level.
Abdank K; Cetin SZ; Abedini A; Susztak K; Eckardt KU; Balzer MS
Nephrol Dial Transplant; 2024 May; 39(6):1044-1047. PubMed ID: 38323426
[No Abstract] [Full Text] [Related]
4. PPARs and the Development of Type 1 Diabetes.
Holm LJ; Mønsted MØ; Haupt-Jorgensen M; Buschard K
PPAR Res; 2020; 2020():6198628. PubMed ID: 32395123
[TBL] [Abstract][Full Text] [Related]
5. Two Specific Sulfatide Species Are Dysregulated during Renal Development in a Mouse Model of Alport Syndrome.
Gessel MM; Spraggins JM; Voziyan PA; Abrahamson DR; Caprioli RM; Hudson BG
Lipids; 2019 Jun; 54(6-7):411-418. PubMed ID: 31197846
[TBL] [Abstract][Full Text] [Related]
6. Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.
Yamada Y; Harada M; Hashimoto K; Guo R; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
Glycoconj J; 2019 Feb; 36(1):1-11. PubMed ID: 30536036
[TBL] [Abstract][Full Text] [Related]
7. Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians.
Tang D; Fakiola M; Syn G; Anderson D; Cordell HJ; Scaman ESH; Davis E; Miles SJ; McLeay T; Jamieson SE; Lassmann T; Blackwell JM
Sci Rep; 2018 Jul; 8(1):10912. PubMed ID: 30026549
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
Tian Y; Yang Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Lu Y; Moriya K; Koike K; Gonzalez FJ; Aoyama T
Glycoconj J; 2016 Dec; 33(6):927-936. PubMed ID: 27318478
[TBL] [Abstract][Full Text] [Related]
9. Quantitative imaging mass spectrometry of renal sulfatides: validation by classical mass spectrometric methods.
Marsching C; Jennemann R; Heilig R; Gröne HJ; Hopf C; Sandhoff R
J Lipid Res; 2014 Nov; 55(11):2343-53. PubMed ID: 25274613
[TBL] [Abstract][Full Text] [Related]
10. Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction.
Marsching C; Rabionet M; Mathow D; Jennemann R; Kremser C; Porubsky S; Bolenz C; Willecke K; Gröne HJ; Hopf C; Sandhoff R
J Lipid Res; 2014 Nov; 55(11):2354-69. PubMed ID: 25267995
[TBL] [Abstract][Full Text] [Related]
11. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.
Harvey DJ
Mass Spectrom Rev; 2015; 34(3):268-422. PubMed ID: 24863367
[TBL] [Abstract][Full Text] [Related]
12. Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.
Kanbe H; Kamijo Y; Nakajima T; Tanaka N; Sugiyama E; Wang L; Fang ZZ; Hara A; Gonzalez FJ; Aoyama T
Arch Toxicol; 2014 Feb; 88(2):367-79. PubMed ID: 24065054
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.
Nakajima T; Kamijo Y; Yuzhe H; Kimura T; Tanaka N; Sugiyama E; Nakamura K; Kyogashima M; Hara A; Aoyama T
Glycoconj J; 2013 Aug; 30(6):553-60. PubMed ID: 23065187
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice.
Kimura T; Nakajima T; Kamijo Y; Tanaka N; Wang L; Hara A; Sugiyama E; Tanaka E; Gonzalez FJ; Aoyama T
PPAR Res; 2012; 2012():174932. PubMed ID: 22645601
[TBL] [Abstract][Full Text] [Related]
15. Role of sulfatide in normal and pathological cells and tissues.
Takahashi T; Suzuki T
J Lipid Res; 2012 Aug; 53(8):1437-50. PubMed ID: 22619219
[TBL] [Abstract][Full Text] [Related]
16. Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.
Kamijo Y; Wang L; Matsumoto A; Nakajima T; Hashimoto K; Higuchi M; Kyogashima M; Aoyama T; Hara A
Clin Exp Nephrol; 2012 Dec; 16(6):959-67. PubMed ID: 22552383
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.
Wang L; Kamijo Y; Matsumoto A; Nakajima T; Higuchi M; Kannagi R; Kyogashima M; Aoyama T; Hara A
Glycoconj J; 2011 May; 28(3-4):125-35. PubMed ID: 21503857
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
Zhang X; Nakajima T; Kamijo Y; Li G; Hu R; Kannagi R; Kyogashima M; Aoyama T; Hara A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1382-8. PubMed ID: 19895791
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress.
Sheng X; Nakajima T; Wang L; Zhang X; Kamijo Y; Takahashi K; Tanaka N; Sugiyama E; Kyogashima M; Aoyama T; Hara A
Tohoku J Exp Med; 2012 May; 227(1):1-12. PubMed ID: 22499158
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
